1. Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010

    Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
    SAN DIEGO, Sept. 21 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC) today announced the company's plans to launch Eagle Eye® Platinum, PrimeWire PRESTIGE™, and the s5™/s5i™ 3.2.1 Software at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting from September 21 - 25 in Washington DC. These are three significant new product innovations and updates to Volcano's unique and innovative intravascular product portfolio. "Volcano's commitment to listening to physicians and delivering the innovative products they ask for will be evident again at this year's TCT with these three new product launches as well as our excitement about our deep ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Quotes

    1. At TCT this year, Volcano is launching three major new products designed to make FFR and intravascular imaging faster and easier...In an economic environment that has challenged innovation, we are pleased to be in a position where we can talk about not one, but three new products. It is this track record of innovation, and our unique, integrated system that combines both imaging and FFR, that has helped us earn the number one market share position in the U.S.
    2. Volcano's commitment to listening to physicians and delivering the innovative products they ask for will be evident again at this year's TCT with these three new product launches as well as our excitement about our deep pipeline of new technologies which includes Image Guided Therapy balloon and IVUS combination devices, Optical Coherence Tomography (OCT), Forward Looking IVUS, Forward Looking ICE, and Impact Microcatheters...Volcano's products have now been used to help clinicians improve patient outcomes in over 1 million interventions. Our track record of innovation and physician support has elevated Volcano to U.S. market leadership in intravascular imaging. Our goal is to provide physicians with tools that will improve patient outcomes and make PCI more efficient and cost-effective. While health care cost concerns are top-of-mind, Volcano innovates in an effort to serve reduce costs and improve quality of care for patients.
  3. Topics Mentioned